Tigermed Consulting Co., Ltd   Report issue

Founded: Hangzhou China (2004)

Organization Overview

First Clinical Trial
2006
NCT00503386
First Marketed Drug
2019
mycophenolate (CellCept)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

TigerMed | TIGERMED AUSTRALIA PTY LIMITED | Tigermed Consulting Co., Ltd